Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Depreciation & Amortization (CF): 2018-2025

Historic Depreciation & Amortization (CF) for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $2.0 million.

  • Evolus' Depreciation & Amortization (CF) rose 79.48% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 25.11%. This contributed to the annual value of $5.3 million for FY2024, which is 3.20% up from last year.
  • Per Evolus' latest filing, its Depreciation & Amortization (CF) stood at $2.0 million for Q3 2025, which was up 12.26% from $1.7 million recorded in Q2 2025.
  • Evolus' Depreciation & Amortization (CF)'s 5-year high stood at $2.0 million during Q1 2021, with a 5-year trough of $853,000 in Q2 2022.
  • For the 3-year period, Evolus' Depreciation & Amortization (CF) averaged around $1.4 million, with its median value being $1.4 million (2024).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first slumped by 54.65% in 2022, then surged by 79.48% in 2025.
  • Evolus' Depreciation & Amortization (CF) (Quarterly) stood at $920,000 in 2021, then increased by 11.63% to $1.0 million in 2022, then soared by 33.69% to $1.4 million in 2023, then rose by 0.07% to $1.4 million in 2024, then skyrocketed by 79.48% to $2.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $2.0 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.6 million for Q1 2025.